Blood · 2007 · 119 citations · 21 references
Life SciencesGeneticsMolecular BiologyCancer GeneticsMolecular OncologyNeoplasiaCancer GenomicsTelomere BiologyTelomere Biology In CancerTelomere DysfunctionTelomere MaintenanceTelomere OrganizationTelomere AbnormalitiesTelomere Dysfunction In CancerTelomere FunctionTelomere InstabilityTelomere Maintenance DefectsTelomere Maintenance MechanismsTelomere Stability
In this study, we explored the telomeric changes that occur in B-chronic lymphocytic leukemia (B-CLL), in which telomere length has recently been demonstrated to be a powerful prognostic marker. We carried out a transcriptomic analysis of telomerase components (hTERT and DYSKERIN), shelterin proteins (TRF1, TRF2, hRAP1, TIN2, POT1, and TPP1), and a set of multifunctional proteins involved in telomere maintenance (hEST1A, MRE11, RAD50, Ku80, and RPA1) in peripheral B cells from 42 B-CLL patients and 20 healthy donors. We found that, in B-CLL cells, the expressions of hTERT, DYSKERIN, TRF1, hRAP1, POT1, hEST1A, MRE11, RAD50, and KU80 were more than 2-fold reduced (P < .001), contrasting with the higher expression of TPP1 and RPA1 (P < .001). This differential expression pattern suggests that both telomerase down-regulation and changes in telomeric proteins composition are involved in the pathogenesis of B-CLL.
21
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Nam W. Kim, Mieczyslaw A. Piatyszek, Karen R. Prowse et al. · Science · 1994 · 7.1K citations
The POT1–TPP1 telomere complex is a telomerase processivity factor
Feng Wang, Elaine R. Podell, Arthur J. Zaug et al. · Nature · 2007 · 709 citations · Full text
Protein Composition of Catalytically Active Human Telomerase from Immortal Cells
Scott B. Cohen, Mark E. Graham, George O. Lovrecz et al. · Science · 2007 · 661 citations